Hadi Yari1, Samira Shabani1, Nahid Nafissi2, Tayebeh Majidzadeh1, Frouzandeh Mahjoubi3. 1. Human Genetics Dept., Medical Biotechnology Department, National Institute of Genetics Engineering and Biotechnology (NIGEB), Pajouhesh Blv, Tehran Karaj High Way, Tehran, Iran. 2. Surgery Department of General Surgery, Iran University of Medical Science, Tehran, Iran. 3. Human Genetics Dept., Medical Biotechnology Department, National Institute of Genetics Engineering and Biotechnology (NIGEB), Pajouhesh Blv, Tehran Karaj High Way, Tehran, Iran. Frouz2@yahoo.com.
Abstract
BACKGROUND AND OBJECTIVES: Cancer initiation and progression could influenced by both genetic and epigenetic events revealing of the overlap between epigenetic and genetic alteration can give important insights into cancer biology. METHODS AND RESULTS: In this experiment ISL1, MGMT, DMNT3b genes were candidate to investigate both methylation status and expression profile by using methylation-specific PCR and real time PCR in 40 breast cancer patients, respectively, also we have assessed relation of the promoter methylation status and expression variation of the target genes. The mean level of methylation of ISL1 and MGMT in tumor tissues were significantly greater than normal tissues. In Contrast, DMNT3b gene was showed lower mean level of methylation in tumor tissue compared to normal tissues, however, this was not statistically significant. Relative expression analysis was displayed a significant reduction in expression level of ISL1 and MGMT in tumor tissues. Furthermore, there was a meaningful association between down expression of ISL1 with histological grade, Her2 and ER status. Moreover, MGMT down expression was significantly associated with tumor sizes. Any remarkable relation was not observed between DMNT3b expression level and clinic pathological features. At the end, significant relation between methylation status and expression level has been revealed. CONCLUSIONS: In this study all observed results were exactly in line with the results were obtained from articles which were based on the methylation research and illustrate that the real-time PCR and methylation methods are in correlated with each other, furthermore, selected genes are capable to use as a potential biomarkers, however, more research on extended cases are needed.
BACKGROUND AND OBJECTIVES: Cancer initiation and progression could influenced by both genetic and epigenetic events revealing of the overlap between epigenetic and genetic alteration can give important insights into cancer biology. METHODS AND RESULTS: In this experiment ISL1, MGMT, DMNT3b genes were candidate to investigate both methylation status and expression profile by using methylation-specific PCR and real time PCR in 40 breast cancer patients, respectively, also we have assessed relation of the promoter methylation status and expression variation of the target genes. The mean level of methylation of ISL1 and MGMT in tumor tissues were significantly greater than normal tissues. In Contrast, DMNT3b gene was showed lower mean level of methylation in tumor tissue compared to normal tissues, however, this was not statistically significant. Relative expression analysis was displayed a significant reduction in expression level of ISL1 and MGMT in tumor tissues. Furthermore, there was a meaningful association between down expression of ISL1 with histological grade, Her2 and ER status. Moreover, MGMT down expression was significantly associated with tumor sizes. Any remarkable relation was not observed between DMNT3b expression level and clinic pathological features. At the end, significant relation between methylation status and expression level has been revealed. CONCLUSIONS: In this study all observed results were exactly in line with the results were obtained from articles which were based on the methylation research and illustrate that the real-time PCR and methylation methods are in correlated with each other, furthermore, selected genes are capable to use as a potential biomarkers, however, more research on extended cases are needed.
Authors: Timo Wittenberger; Sara Sleigh; Daniel Reisel; Michal Zikan; Benjamin Wahl; Marianna Alunni-Fabbroni; Allison Jones; Iona Evans; Julian Koch; Tobias Paprotka; Harri Lempiäinen; Tamas Rujan; Brigitte Rack; David Cibula; Martin Widschwendter Journal: Epigenomics Date: 2014-06 Impact factor: 4.778
Authors: Donald L Weaver; Takamaru Ashikaga; David N Krag; Joan M Skelly; Stewart J Anderson; Seth P Harlow; Thomas B Julian; Eleftherios P Mamounas; Norman Wolmark Journal: N Engl J Med Date: 2011-01-19 Impact factor: 91.245
Authors: Donato F Romagnolo; Kevin D Daniels; Jonathan T Grunwald; Stephan A Ramos; Catherine R Propper; Ornella I Selmin Journal: Mol Nutr Food Res Date: 2016-06 Impact factor: 5.914
Authors: Patrick A Adegboyega; Randy C Mifflin; John F DiMari; Jamal I Saada; Don W Powell Journal: Arch Pathol Lab Med Date: 2002-07 Impact factor: 5.534
Authors: Jordana T Bell; Athma A Pai; Joseph K Pickrell; Daniel J Gaffney; Roger Pique-Regi; Jacob F Degner; Yoav Gilad; Jonathan K Pritchard Journal: Genome Biol Date: 2011-01-20 Impact factor: 13.583